PharmaVoice Logo

Healthcare Leaders Hub

Beijing unveils blueprint for biomedical dominance by 2030

Pharma Tech

Beijing unveils blueprint for biomedical dominance by 2030

Outlining a five-year biomedical plan, China wants to expand its global role beyond just pipeline innovation.

Read Full Article
Biocon receives EMA CHMP approval for Pertuzumab biosimilar

Express Pharma

Biocon receives EMA CHMP approval for Pertuzumab biosimilar

Biocon Biologics announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the granting of a marketing authorisation to its Pertuzumab biosimilar as 420 mg concentrate solution for infusion, under the brand name Pebrilzo, for the treatment of HER2-positive breast cancer across […] The post Biocon receives EMA CHMP approval for Pertuzumab biosimilar appeared first on Express Pharma.

Read Full Article
Telix to acquire ITM in deal worth up to $2.35bn

Pharma Tech

Telix to acquire ITM in deal worth up to $2.35bn

Telix Pharmaceuticals has agreed to acquire ITM Isotope Technologies Munich in a transaction valued at up to $2.35bn, combining Telix’s operations with ITM’s radioisotope production business and late-stage treatment candidate ITM-11.

Read Full Article
How DFE Pharma supports confident continuous manufacturing decisions

Pharma Tech

How DFE Pharma supports confident continuous manufacturing decisions

DFE Pharma supports confident continuous manufacturing decisions with CM-ready excipients, non-GMP testing and expert support.

Read Full Article
Akums announces DCGI-approved triple therapy for H. pylori infection

Express Pharma

Akums announces DCGI-approved triple therapy for H. pylori infection

Akums Drugs & Pharmaceuticals has announced the development of a DCGI-approved Clarithromycin + Vonoprazan + Amoxicillin Combikit for the treatment of Helicobacter pylori (H. pylori) infection in adults. The development is part of the company’s ongoing work in pharmaceutical formulation and reflects the growing focus within healthcare on treatment approaches that consider both therapeutic requirements […] The post Akums announces DCGI-approved triple therapy for H. pylori infection appeared first on Express Pharma.

Read Full Article

Sponsored content

Featured promotional

Jeplus.in
Sponsored

Jeplus.in

Purchase All Medicines.Get 10% Offer

News

Latest stories

Pharma Tech

Sep 21, 2026, 2:36 PM

Beijing unveils blueprint for biomedical dominance by 2030

Outlining a five-year biomedical plan, China wants to expand its global role beyond just pipeline innovation.

ET Pharma

Sep 21, 2026, 1:43 PM

ADARx Pharmaceuticals targets $1.74 billion valuation in US IPO

The San Diego, California -based ‌company is aiming to raise up to $371.9 million in the IPO by offering 21.9 million shares priced between $15 and $17 each.

ET Pharma

Sep 21, 2026, 1:00 PM

Novo Nordisk aims to launch more than five blockbuster drugs by 2030, CEO says

The company is racing to reassure markets that it can navigate patent expirations for semaglutide - the active ingredient in its anti-obesity drugs Ozempic and Wegovy franchises - in the early 2030s.

PharmaShots

Sep 21, 2026, 12:29 PM

Corcept Therapeutics Reports the CHMP Positive Opinion of Lifyorli (Relacorilant) to Treat Platinum-Resistant Ovarian Cancer

Shots: Ref: Corcept Therapeutics  |  Image: Corcept Therapeutics  | Press Release PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com The post Corcept Therapeutics Reports the CHMP Positive Opinion of Lifyorli (Relacorilant) to Treat Platinum-Resistant Ovarian Cancer appeared first on PharmaShots.

PharmaShots

Sep 21, 2026, 11:30 AM

AstraZeneca Reports the CHMP Positive Opinion for Klygefa to Treat Generalised Myasthenia Gravis

Shots: Ref: PRnewswire  |  Image: AstraZeneca  |Press Release PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com The post AstraZeneca Reports the CHMP Positive Opinion for Klygefa to Treat Generalised Myasthenia Gravis appeared first on PharmaShots.

PharmaShots

Sep 21, 2026, 10:30 AM

Grünenthal to Acquire Bayer’s Stivarga for ~€375M

Shots: Ref: PRnewswire  |  Image: Grünenthal & Bayer  | Press Release PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com The post Grünenthal to Acquire Bayer’s Stivarga for ~€375M appeared first on PharmaShots.

News

Latest industry coverage

Google News

Sep 21, 2026, 10:11 PM

Double-Wall Containment Gloves Market Forecast to 2035: Growth Accelerates on Pharma Cleanroom Demand - IndexBox

Double-Wall Containment Gloves Market Forecast to 2035: Growth Accelerates on Pharma Cleanroom Demand  IndexBox

Google News

Sep 21, 2026, 10:01 PM

Teva Pharmaceutical Industries Ltd (TEVA) Stock Up 3.5% but GF V - GuruFocus

Teva Pharmaceutical Industries Ltd (TEVA) Stock Up 3.5% but GF V  GuruFocus

Google News

Sep 21, 2026, 9:41 PM

Pharmaceutical Companies Push Trump Administration to Protect China Deals - WSJ

Pharmaceutical Companies Push Trump Administration to Protect China Deals  WSJ

Google News

Sep 21, 2026, 9:40 PM

Lilly breaks ground in Houston, one of ten U.S. manufacturing sites announced since 2020 - PR Newswire

Lilly breaks ground in Houston, one of ten U.S. manufacturing sites announced since 2020  PR Newswire

Google News

Sep 21, 2026, 9:28 PM

Novo Nordisk and Anthropic Announce Collaboration to Advance Drug Discovery With Claude - BioBuzz

Novo Nordisk and Anthropic Announce Collaboration to Advance Drug Discovery With Claude  BioBuzz

Google News

Sep 21, 2026, 9:00 PM

Cipher Pharmaceuticals Announces the Appointment of Rajiv De Silva to its Board of Directors - marketscreener.com

Cipher Pharmaceuticals Announces the Appointment of Rajiv De Silva to its Board of Directors  marketscreener.com

Google News

Sep 21, 2026, 9:00 PM

Cipher Pharmaceuticals Announces the Appointment of Rajiv De Silva to its Board of Directors - Yahoo Finance

Cipher Pharmaceuticals Announces the Appointment of Rajiv De Silva to its Board of Directors  Yahoo Finance

Google News

Sep 21, 2026, 8:41 PM

StockWatch: Novo’s 2030 Strategy Underwhelms Investors at Capital Markets Day - genengnews.com

StockWatch: Novo’s 2030 Strategy Underwhelms Investors at Capital Markets Day  genengnews.com

Google News

Sep 21, 2026, 8:23 PM

Novo Nordisk’s stock tumbles as doubts persist about Ozempic maker’s strategy - MarketWatch

Novo Nordisk’s stock tumbles as doubts persist about Ozempic maker’s strategy  MarketWatch

Sponsored placement

Featured promotions

Jeplus.in
Sponsored

Jeplus.in

Purchase All Medicines.Get 10% Offer